FDA Warns of Rare Stroke Risk With MS Drug

Alternative Medicine

WEDNESDAY, Dec. 5, 2018 — A new warning has been added to the multiple sclerosis drug Lemtrada (alemtuzumab) after rare reports of patients suffering strokes and tears in the lining of the arteries in the head and neck, the U.S. Food and Drug…
Source: FDA Warns of Rare Stroke Risk With MS Drug

Leave a Reply

Your email address will not be published. Required fields are marked *